#Quest Diagnostics #Fortune #Corporate Reputation

Quest Diagnostics' Remarkable Achievement

Quest Diagnostics, listed on the NYSE as DGX, has recently been honored for the 11th consecutive year by Fortune magazine as one of the 2025 World's Most Admired Companies. This prestigious recognition highlights the company's ongoing commitment to excellence and innovation in the field of diagnostic information services.

What Makes This Award Significant?

The selection process for this accolade is rigorous, evaluating companies on nine essential criteria related to corporate reputation. These attributes include not just the quality of products and services, but also the organization's approach to innovation, community engagement, social responsibility, and talent management. The fact that Quest has maintained a position on this esteemed list for over a decade is a testament to its unwavering commitment to its mission: to create a healthier world, one life at a time.

Jim Davis, Chairman, CEO, and President of Quest Diagnostics, articulated the company’s ethos, saying, "Every day, the more than 55,000 colleagues of Quest Diagnostics bring our purpose to life… Their commitment to living our purpose in service to our customers and patients is the reason we continue to be recognized among Fortune's World's Most Admired Companies."

Outstanding Performance Across Key Metrics

In addition to being recognized among the world's most admired companies, Quest Diagnostics achieved a remarkable ranking within the healthcare industry, securing the third position in the